Economic analysis of drug-eluting coronary stents in Brazil: A choice for all or just for a few patients?;Análise econômica dos stents coronarianos farmacoló gicos no Brasil: Para todos ou para poucos pacientes?

Arquivos Brasileiros de Cardiologia

Volumn 88, Issue 4, 2007, Pages

  Rassi Jr , Anis ^a  

^a Anis Rassi Hospital   (Brazil)

Author keywords

Angioplasty, transluminal, percutaneous coronary; National Health System (BR); Pharmacologics stents; Stents economics

Indexed keywords

RAPAMYCIN;

COST BENEFIT ANALYSIS; DRUG COST; DRUG ELUTING STENT; ECONOMIC ASPECT; EDITORIAL; HEALTH CARE PLANNING; HUMAN; MEDICAL LITERATURE; PUBLIC HEALTH SERVICE; BRAZIL; CORONARY ARTERY DISEASE; ECONOMICS;

BRAZIL; CORONARY DISEASE; DRUG-ELUTING STENTS; HUMANS;

EID: 34250023527     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: None     Document Type: Editorial

References (8)

1. Mehta NJ, Khan IA. Cardiology's 10 greatest discoveries of the 20th century. Tex Heart Inst J. 2002; 29: 164-71.
2. Braunwald E. The Simon Dack lecture: cardiology: the past, the present, and the future. J Am Coll Cardiol. 2003; 42: 2031-41.
3. Meltzer MI. Introduction to health economics for physicians. Lancet. 2001; 358: 993-8.
4. Mark DB, Hlatky MA. Medical economics and the assessment of value in cardiovascular medicine: Part I. Circulation. 2002; 106: 516-20.
5. Polanczyk CA, Wainstein MV, Ribeiro JP. Custo-efetividade dos stents recobertos com rapamicina em procedimentos percutâneos coronarianos no Brasil. Arq Bras Cardiol. 2007; 88 (4): 464-474.
6. Ryan J, Cohen DJ. Are drug-eluting stents cost-effective? It depends on whom you ask. Circulation. 2006; 114: 1736-43.
7. Grines CL, Bonow RO, Casey DE Jr, Gardner TJ, Lockhart PB, Moliterno DJ, et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. J Am Coll Cardiol. 2007; 49: 734-9.
8. Araújo DV, Lima VC, Ferraz MB. Análise de impacto do stent farmacológico no orçamento do Sistema Único de Saúde. Arq Bras Cardiol. 2007; 88 (4): 458-463.